Mechanisms and Treatments of Neurodegenerative Diseases
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".
Deadline for manuscript submissions: closed (30 October 2021)
Special Issue Editors
Interests: cognitive impairment; frailty syndrome; neurodevelopemntal disorders; depression; neuropathy; sleep; envirnomental factors; comorbidty; immune alterations; metabolic alterations; biomarkers
Special Issues, Collections and Topics in MDPI journals
2. Frailty Research Organized Group (FROG), University of Valencia, 46010 Valencia, Spain
Interests: sleep; sleep assessment methods; inflammatory ; biomarkers; mental health; nursing; cognitive impairment
Special Issues, Collections and Topics in MDPI journals
2. Frailty Research Organized Group (FROG), University of Valencia, 46010 Valencia, Spain
Interests: aging; cognitive impairment; delirium; quality of life; frailty; sarcopenia; exercise
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurodegenerative diseases encompass a number of ailments that primarily affect neurons in the human nervous system. Neurons are the building blocks of the nervous system. Normally, neurons do not reproduce or replace themselves, so the body cannot replace them with other neurons when they are damaged.
Neurodegenerative diseases are incurable and debilitating, resulting in the progressive degeneration and/or death of neurons. This causes several deficits that impair quality of life and increase the odds of morbidity and premature mortality in affected individuals. Both pharmacological and nonpharmacological interventions can delay the progression of such diseases and, in some cases, the treatment of comorbid conditions can improve the quality of life of the individuals with neurodegenerative diseases.
This Special Issue wishes to shed new light on this exciting and insightful field of research from a multidisciplinary perspective. This Special Issue, “Mechanisms and Treatments of Neurodegenerative Diseases” will reflect the intense interplay between neurology and neuroscience as well as with other health sciences at the leading edge of this growing research field, which has led to suggestions of new opportunities for improving the diagnosis, treatment, and care of patients with neurodegenerative diseases, or to prevent adverse outcomes. In this Special Issue, the readership will find accounts of relevant research carried out by numerous healthcare professionals and researchers with extensive knowledge on basic and clinical settings, and the intention is to address new topics of interest of specific importance within the spectrum of basic research to clinical practice.
Prof. Dr. Omar Cauli
Dr. Vanessa Ibáñez-del Valle
Dr. Pilar Pérez-Ros
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Alzheimer’s disease
- Parkinson’s disease
- dementia
- autoimmune disorders
- biomarkers
- gender differences
- cellular pathology
- treatment
- palliative care
- comorbidity
- risk and prognostic factors
- chronic conditions
- caregiver
- health education
